424B4PROSPECTUS
Jun 30, 2026Final prospectus0001213900-26-073848
Sources: sec-harvest, nasdaq
Now trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 2h ago
From SEC filings, latest FY ending Dec 31, 2025 · CIK 0001560293.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $3.94M | $3.28M | $2.93M | $691K | $160K |
| Gross profit | $2.36M | $1.71M | $1.24M | -$641K | $105K |
| Operating income | -$12.79M | -$13.77M | -$15.73M | -$18.73M | -$6.46M |
| Net income | -$12.56M | -$13.67M | -$15.58M | -$18.92M | -$7.05M |
| R&D expense | $2.15M | $2.6M | $3.16M | $2.83M | $1.72M |
| Cash & equivalents | $3.76M | $6.54M | $2.43M | $2.13M | $2.92M |
| Total assets | $10.76M | $9.84M | $6.35M | $11.09M | $9.27M |
| Total liabilities | $5.72M | $3.87M | $5.57M | $4.84M | $16.19M |
| Shareholders' equity | $5.04M | $5.97M | $778K | $6.25M | -$20.55M |
Tenon Medical is a medical-device company focused on surgical implants and instruments for sacroiliac joint disorders.
Tenon Medical operates in orthopedic medtech, where surgeon adoption, payer coverage, clinical outcomes, sales productivity, and regulatory compliance drive performance.
EDGAR filings resolved from TNON / CIK 0001560293.